Indication
Postexposure plague prophylaxis
Postexposure plague prophylaxis refers to the preventative antimicrobial management of asymptomatic individuals following documented or suspected exposure to the Gram-negative bacterium *Yersinia pestis*. Read more about Postexposure plague prophylaxis
140 drugs 81 manufacturers
Drugs that treat it
Common Postexposure plague prophylaxis therapies.
LEVOFLOXACIN
CIPROFLOXACIN (ciprofloxacin HCl)
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPostexposure plague prophylaxis refers to the preventative antimicrobial management of asymptomatic individuals following documented or suspected exposure to the Gram-negative bacterium *Yersinia pestis*.
This clinical indication applies to populations with high-risk encounters, such as close contact with patients or animals exhibiting pneumonic plague, direct contact with infectious body fluids or tissues, laboratory accidents, or potential exposure following an intentional aerosolized bioterrorism release.
Pathophysiologically, preventive therapy aims to eradicate inoculating bacteria during the incubation period before the organism disseminates to produce fulminant respiratory failure in pneumonic plague, severe lymphatic necrosis in bubonic plague, or overwhelming endotoxemia and multiorgan failure in septicemic plague.
- cdc.gov
Postexposure plague prophylaxis refers to the preventative antimicrobial management of asymptomatic individuals following documented or suspected exposure to the Gram-negative bacterium *Yersinia pestis* This clinical indication applies to populations with high-risk encounters, such as close contact with patients or animals exhibiting pneumonic plague, direct contact with infectious body fluids or tissues, laboratory accidents, or potential exposure following an intentional aerosolized bioterror...
- nih.gov
Postexposure plague prophylaxis refers to the preventative antimicrobial management of asymptomatic individuals following documented or suspected exposure to the Gram-negative bacterium *Yersinia pestis* This clinical indication applies to populations with high-risk encounters, such as close contact with patients or animals exhibiting pneumonic plague, direct contact with infectious body fluids or tissues, laboratory accidents, or potential exposure following an intentional aerosolized bioterror...
- cdc.gov
This clinical indication applies to populations with high-risk encounters, such as close contact with patients or animals exhibiting pneumonic plague, direct contact with infectious body fluids or tissues, laboratory accidents, or potential exposure following an intentional aerosolized bioterrorism release
- youtube.com
Pathophysiologically, preventive therapy aims to eradicate inoculating bacteria during the incubation period before the organism disseminates to produce fulminant respiratory failure in pneumonic plague, severe lymphatic necrosis in bubonic plague, or overwhelming endotoxemia and multiorgan failure in septicemic plague
Personalize your experience
Follow Postexposure plague prophylaxis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.